2026 Nobel Prize: Three Scientists Win Medicine Award for Optogenetics

2026 Nobel Prize: Three Scientists Win Medicine Award for Optogenetics

American scientist Karl Deisseroth, German scientists Peter Hegemann and Georg Nagel have won the 2026 Nobel Prize in Physiology or Medicine for discoveries that led to optogenetics, a technology that allows scientists to control the activity of nerve cells using light.

The Nobel Assembly at Karolinska Institutet announced the award on Monday, October 5, recognising the trio for their discoveries concerning light-gated ion channels and optogenetics.

Their work has transformed neuroscience, giving researchers a highly precise way to switch individual nerve cells on or off and study how the brain controls functions such as movement, memory, emotions and behaviour.

The breakthrough began with research into how microscopic algae respond to light. Peter Hegemann studied the light-sensitive mechanisms of algae in the 1990s, while Georg Nagel helped demonstrate that a light-sensitive protein known as channelrhodopsin could function as an ion channel.

Their work showed that light could be used to trigger electrical activity in cells. The discovery eventually provided the foundation for optogenetics, which combines genetics and optics to manipulate specific cells with pulses of light.

READ ALSO:

• Temi Nkem Wins N160m BBNaija Season 11 Grand Prize
• Nigeria — My Country of Destiny
• Ex-APC Women Leader Found Dead With Throat Slit in Bauchi
• Supreme Court Ruling: INEC Moves to Clarify Fate of 2027 Candidates

Karl Deisseroth, a neuroscientist at Stanford University, subsequently demonstrated that the technology could be used in nerve cells. His research showed that light-sensitive proteins could be introduced into neurons and used to control their activity.

The technique has since become an important research tool worldwide. Scientists can genetically make selected populations of neurons sensitive to light and then use precisely delivered light to activate or silence them.

The Nobel Assembly said optogenetics has made it possible to switch individual nerve cells on or off in a living brain, allowing researchers to investigate the complex networks underlying brain function.

Beyond basic research, the technology is also being investigated for potential medical applications. Researchers are exploring optogenetic approaches to restore vision in people affected by certain forms of blindness, while other studies are examining whether the technology could contribute to future treatments for neurological disorders.

Deisseroth is based at Stanford University in the United States, while Hegemann is affiliated with Humboldt University of Berlin and Nagel with the University of Würzburg in Germany.

The three laureates will share the 2026 Nobel Prize award of 12 million Swedish kronor.

The Nobel Prize in Physiology or Medicine traditionally opens the annual Nobel announcements, with the prizes for physics, chemistry, literature, peace and economic sciences following during Nobel week.

The 2026 medicine award highlights a scientific breakthrough that has fundamentally changed how researchers study the brain, particularly their ability to examine the role of specific nerve cells with unprecedented precision.

2026 Nobel Prize: Three Scientists Win Medicine Award for Optogenetics